2 abstracts of major importance for advancing the treatment of pulmonary vascular diseases, and pulmonary hypertension in particular, were presented today at ATS 2023 International Conference in Washington by Julien Guiot from CHU de Liège.
The studies conducted with LungQ™ AVX, Thirona’s AI-based pulmonary artery-vein phenotyping, show that AVX allows for non-invasive detection of arterial and venous alterations in the lungs, potentially enabling early diagnosis of P(A)H and differentiating between different groups of the disease (WHO classification).
Artificial Intelligence-Based Analysis Differentiates PAH From PH Using Non-Contrast Chest CT Scans
Visit our booth 939 to talk to our experts and explore how we can partner together for new drug and treatment development.
Read the blog article by Leticia Gallardo Estrella leading the deep learning engineering team at Thirona for more background.